ANKRD13D

Across TCGA pan-cancer cohorts, ANKRD13D RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated ANKRD13D data layer compared with 4 for mutation status and 3 for mass-spec protein.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher ANKRD13D RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ANKRD13D expression acts as an unfavorable survival marker, although some lineages such as SCLC and SKCM show a favorable association.

KIRC, ACC, and UVM are the cancer types where ANKRD13D RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.527	0.717	<.001	168	view →
ACC	DFS	Median	All	0.246	0.643	<.001	118	view →
UVM	DFS	Median	All	0.303	0.729	<.001	111	view →
COAD	OS	Tertile	All	0.787	0.919	.008	70	view →
LIHC	OS	Tertile	All	0.600	0.749	.004	38	view →
LGG	DFS	Median	All	0.671	0.798	<.001	36	view →
OV	DFS	Median	IV	0.356	0.561	.010	30	view →
SCLC	OS	Quartile	All	0.472	0.147	.002	28	view →
PRAD	DFS	Median	All	0.808	0.959	<.001	20	view →
STAD	OS	Tertile	II,III,IV	0.460	0.664	.011	15	view →
KIRP	DFS	Quartile	All	0.780	0.901	.028	14	view →
SKCM	DFS	Tertile	III,IV	0.453	0.179	.007	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

ANKRD13D–KIRC (OS)

Open the KIRC breakdown →